← SynDRA
GSK-2801
SynDRA canonical compound SYN0060131 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | BAZ2A | BAZ2B | ZNF215 |
|---|
| Mechanism of action | bromodomain inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- BAZ2A INHIBITOR
- BAZ2B BINDER
- BET bromodomain inhibitor
- BAZ2B INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- GSK 2801
- GSK2801
- KB-146016
- Gsk2801
- RefChem:144553
- MFCD26142953
- GTPL8233
- orb1305490
- SCHEMBL22339997
- SCHEMBL29352262
- GLXC-05263
- EX-A2287
- GSK2801?
- BDBM50148270
- NSC772393
- s7231
- AKOS026750485
- CCG-268313
- NSC-772393
- NCGC00356119-01
- NCGC00356119-06
- AC-38053
- AS-72192
- BP-25352
- DA-63913
- FG137682
- HY-15658
- GSK2801, >=98% (HPLC)
- T2436
- N11415
- F865724
- BRD-K48062199-001-01-8
Look up GSK-2801 in the interactive SynDRA portal →